OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 61 filers reported holding OYSTER PT PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $386,000 | -23.3% | 33,139 | +20.3% | 0.00% | – |
| Q4 2021 | $503,000 | +53.8% | 27,546 | 0.0% | 0.00% | – |
| Q3 2021 | $327,000 | -77.1% | 27,546 | -66.8% | 0.00% | – |
| Q2 2021 | $1,427,000 | +7.0% | 82,964 | +13.8% | 0.00% | – |
| Q1 2021 | $1,334,000 | +1.2% | 72,928 | +4.2% | 0.00% | -100.0% |
| Q4 2020 | $1,318,000 | -9.2% | 70,011 | +1.9% | 0.00% | 0.0% |
| Q3 2020 | $1,451,000 | +238.2% | 68,708 | +363.2% | 0.00% | – |
| Q2 2020 | $429,000 | +2.1% | 14,832 | +23.6% | 0.00% | – |
| Q1 2020 | $420,000 | +42.9% | 11,999 | 0.0% | 0.00% | – |
| Q4 2019 | $294,000 | – | 11,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |